Skip to content
WeighLab
Menu
Ranked #88 · Grade C

NuuVim review

NuuVim is a Texas-based DTC telehealth program offering compounded semaglutide and tirzepatide in both injectable and oral forms — oral access is uncommon here — plus limited brand-name Ozempic and Zepbound.

Visit NuuVim Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. See our disclosure.
Semaglutide
$79/mo (all doses, 3-mo plan, new patients only, compounded)
Tirzepatide
$133/mo (all doses, 3-mo plan, new patients only, compounded)
Coverage
Coverage not published
Brand-name
Yes

Semaglutide · modeled / year

$948

Tirzepatide · modeled / year

$1,596

Pricing verified August 2026

The Index scorecard

NuuVim scored on our six Cost-Efficiency Index factors. See the methodology.

Normalized Cost/Month93/100
Price Transparency94/100
Nationwide Access24/100
Formulation Options90/100
Clinical Oversight54/100
Contract Flexibility47/100

Where the value is

  • Low compounded entry pricing — semaglutide from $79/mo, tirzepatide from $133/mo, flat all-dose pricing
  • Both injectable and oral compounded options for semaglutide and tirzepatide (oral access is uncommon)
  • LegitScript Certified and HIPAA-compliant
  • Two named compounding pharmacy partners (Hallandale Pharmacy and Pharmacy Hub), both vetted in our directory
  • Operating legal entity disclosed: NuuVim LLC, Texas governing law

The tradeoffs

  • There is no month-to-month plan: every rate is billed as one three-month payment
  • The advertised $79 and $133 are introductory rates for customers new to GLP-1s; on renewal they become $133 and $199.67
  • The site's own llms.txt advertises pricing, FAQ and terms files that all 404
  • No state count is published

The bottom line

Best for: Cost-first shoppers who want low-cost compounded GLP-1s (injection or oral), flat all-dose pricing. NuuVim is a Texas-based DTC telehealth program offering compounded semaglutide and tirzepatide in both injectable and oral forms — oral access is uncommon here — plus limited brand-name Ozempic and Zepbound.

Ranked #88 of 539 providers on the Cost-Efficiency Index — see our #1 pick, CoreAge Rx, for comparison.

Compare with other providers

All 538 other providers we've modeled, in Cost-Efficiency Index order. See the ranked alternatives to NuuVim.

The 24 programs nearest this one

Pricing, states and verification reflect NuuVim's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on NuuVim's site. Not medical advice; see our disclosure.

← Back to the value leaderboard